Clinical Trial Update: A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 pilot trial evaluating oral Triamcinalone in patients with androgen-independent prostate cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Triamcinalone (Triamcinalone)

Snippet

Sponsor: Stanford University | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED